Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ginkgo Bioworks Holdings Inc DNA

Alternate Symbol(s):  DNABW

Chemicals Specialty Chemicals
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration... see more

Recent & Breaking News (NYSE:DNA)

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ginkgo Bioworks Holdings, Inc. - DNA

PR Newswire December 13, 2021

Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Ginkgo Bioworks Holdings, Inc. - DNA

Newsfile December 13, 2021

DNA Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of January 18, 2022 Deadline in Securities Fraud Class Action Lawsuit

PR Newswire December 11, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ginkgo Bioworks Holdings, Inc. - DNA

Newsfile December 11, 2021

GINKGO BIOWORKS HOLDINGS, INC. F/K/A SOARING EAGLE ACQUISITION CORP. (DNA, SRNG) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc.

Newsfile December 9, 2021

Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Ginkgo Bioworks Holdings, Inc. (DNA)

Newsfile December 8, 2021

DNA; SRNG Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ginkgo Bioworks Holdings Inc. (f/k/a Soaring Eagle Acquisition Corp.) Shareholders of Class Action and Lead Deadline: January 18, 2022

Newsfile December 7, 2021

Concentric by Ginkgo Confirms Detection of Omicron Variant through COVID-19 Air Travel Biosecurity Collaboration with CDC and XpresCheck

PR Newswire December 7, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Ginkgo Bioworks Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 18, 2022 - DNA

PR Newswire December 6, 2021

GINKGO BIOWORKS HOLDINGS, INC. F/K/A SOARING EAGLE ACQUISITION CORP. (DNA, SRNG) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc.

Newsfile December 6, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ginkgo Bioworks Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 18, 2022 - DNA

Newsfile December 5, 2021

Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Ginkgo Bioworks Holdings, Inc. (DNA) and Encourages Investors with Significant Losses to Contact the Firm

Newsfile December 5, 2021

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. Investors With Losses Over $100K to Secure Counsel Before Important Deadline in First Filed Securities Class Action Commenced by the Firm - DNA, SRNG

PR Newswire December 5, 2021

LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors With Substantial Losses to Contact the Firm

PR Newswire December 4, 2021

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile December 3, 2021

DNA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Ginkgo Bioworks Holdings, Inc.

Newsfile December 3, 2021

ROSEN, A RANKED AND LEADING FIRM, Encourages Ginkgo Bioworks Holdings, Inc. f/k/a Soaring Eagle Acquisition Corp. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - DNA, SRNG

Business Wire December 3, 2021

DNA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 18, 2022 in the Class Action Filed on Behalf of Ginkgo Bioworks Holdings, Inc. Limited Shareholders

Newsfile December 3, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ginkgo Bioworks Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 18, 2022 - DNA

Newsfile December 3, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ginkgo Bioworks Holdings, Inc. - DNA

PR Newswire December 2, 2021